Serum interleukin-6 is associated with hypocalcemia, hypoferritinemia and hyperkalemia in end-stage renal disease patients. Ital J Med [Internet]. 2022 Dec. 30 [cited 2025 Jul. 4];16(1). Available from: https://www.italjmed.org/ijm/article/view/1550